日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties"

对“具有改进药理特性的强效、选择性吡咯并嘧啶PDE11A4抑制剂”的更正

Mahmood, Shams Ul; Boddu, Rama Krishna; Eberhard, Jeremy; Hoffman, Charles S; Gordon, John; Colussi, Dennis; Childers, Wayne; Amurrio, Elvis; Danaher, Marie; Kelly, Michy P; Rotella, David P

Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties

具有改进药理特性的高效、选择性吡咯并嘧啶类PDE11A4抑制剂

Mahmood, Shams Ul; Boddu, Rama Krishna; Eberhard, Jeremy; Hoffman, Charles S; Gordon, John; Colussi, Dennis; Childers, Wayne; Amurrio, Elvis; Danaher, Marie; Kelly, Michy P; Rotella, David P

Age-Related Increases in PDE11A4 Protein Expression Trigger Liquid-Liquid Phase Separation (LLPS) of the Enzyme That Can Be Reversed by PDE11A4 Small Molecule Inhibitors.

与年龄相关的 PDE11A4 蛋白表达增加会引发该酶的液-液相分离 (LLPS),而 PDE11A4 小分子抑制剂可以逆转这一现象

Amurrio Elvis, Patel Janvi H, Danaher Marie, Goodwin Madison, Kargbo Porschderek, Klimentova Eliska, Lin Sonia, Kelly Michy P

First Demonstration of In Vivo PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory Disorders

首次证实体内PDE11A4靶点结合可用于治疗与年龄相关的记忆障碍

Mahmood, Shams Ul; Eberhard, Jeremy; Hoffman, Charles S; Colussi, Dennis; Gordon, John; Childers, Wayne; Amurrio, Elvis; Patel, Janvi; Kelly, Michy P; Rotella, David P